Click to cancel search
Login
Sign Up
Home Page
How It Works
Our Story
Symptom Checker
Second Opinion Finder
Newsroom
Partner With Us
MediFind Pro
FAQ
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
Submit Feedback
Advertising Policy
Privacy Policy
Terms & Conditions
Condition
Condition
Doctor
Symptom
Condition
Click to search for condition or expert
Login
Sign Up
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Dowling-Meara Epidermolysis Bullosa Simplex
Symptoms, Doctors, Treatments, Research & More
Overview
Condition 101
Find a Doctor
Latest Research
Clinical Trials
Active Clinical Trials
Clinical Trial
Other
Status:
Recruiting
Study Type:
Other
Participants:
100
Start Date:
March 2, 2020
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
25
Start Date:
June 14, 2018
Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
Clinical Trial
Biological
Status:
Active, not recruiting
Study Type:
Biological
Participants:
4
Start Date:
May 7, 2018
A Phase II Study of Beremagene Geperpavec (KB103), a Non-Integrating, Replication-Incompetent Herpes Simplex Virus 1 (HSV-1) Vector Expressing the Human Collagen VII (COL7) Protein, for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
Clinical Trial
Procedure
Status:
Active, not recruiting
Study Type:
Procedure
Participants:
16
Start Date:
November 28, 2017
Computational Drug Repurposing for Epidermolysis Bullosa Simplex
Clinical Trial
Drug
Status:
Active, not recruiting
Study Type:
Drug
Participants:
8
Start Date:
May 2016
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
